Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria

References

• Buist AS, McBurnie MA, Vollmer WM, et al. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50
   PubMed Web of Science ®Google Scholar
• Bridevaux PO, Probst-Hensch NM, Schindler C. Prevalence of airflow obstruction in smokers and never smokers in Switzerland. Eur Respir J 2010;36:1259-69
   PubMed Web of Science ®Google Scholar
• Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. EurRespir J 2006;28:523-32
   PubMed Web of Science ®Google Scholar
• Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med 2011;9:7
   PubMed Web of Science ®Google Scholar
• Adeloye D, Chua S, Lee C, et al. Global health epidemiology reference group (GHERG). Global health epidemiology reference group (GHERG). Global and regional estimates of COPD prevalence: Systematic review and meta?analysis J Glob Health 2015;5:1-17
   Web of Science ®Google Scholar
• Mitsiki E, Bania E, Varounis C, et al. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study, Int J Chron Obstruct Pulmon Dis 2015;10:1371-82
   PubMed Web of Science ®Google Scholar
• Kavalski E. Balkansmoke: tobacco and the making of modern Bulgaria. EurAsiaStud 2014;66:1194-5
   Google Scholar
• Jansson SA, Backman H, Stenling A, et al. Health economic costs of COPD in Sweden by disease severity – Has it changed during a ten years period? Respir Med 2013;107:1931-8
   PubMed Web of Science ®Google Scholar
• Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis 2014;9:289-300
   PubMed Web of Science ®Google Scholar
• Trupin L, Earnest G, San Pedro M. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003;22:462-469
   PubMed Web of Science ®Google Scholar
• van Boven JFM, Vegtera S, van der Molen T, et al. COPD in the working age population: the economic impact on both patients and government. COPD: J Chron Obstruct Pulmon Dis 2013;10:629-39
   PubMed Web of Science ®Google Scholar
• Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J 2002;20:799-805
   PubMed Web of Science ®Google Scholar
• Cupurdija V. Economic impact of leading prosperity diseases: COPD in South East Europe. Front Public Health 2015;3:50
   PubMedGoogle Scholar
• Würtz ET, Schlünssen V, Malling TH, et al. Occupational COPD among Danish never-smokers: a population-based study. Occup Environ Med 2015;72:456-9
   PubMed Web of Science ®Google Scholar
• Josephs L, Johnson M, Orlando R, et al. An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction. Eur Respir J 2015;46:59
   Google Scholar
• Guillien A, Puyraveau M, Soumagne T, et al. Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study. Eur Respir J 2015;47:16-18
   Web of Science ®Google Scholar
• Pocket guide to COPD diagnosis, management and prevention, A guide for healthcare professionals. Updated 2015. http://www.goldcopd.it/materiale/2015/GOLD_Pocket_2015.pdf. Accessed June 25, 2016
   Google Scholar
• National Health Insurance Fund. National Framework contract. 2015. http://www.nhif.bg/web/guest/699. http://www.nsi.bg/bg. Accessed June 25, 2016
   Google Scholar
• Contract No RD-SB-01-2 from 29/12/2014 for acceptance on volumes and prices on medical care or 2015 between national Health case and Bulgarian medical union. 2015. http://www.nhif.bg/c/document_library/get_file?uuid=383568bd-ec85-4c46-882a-b79a9fd9417b&filename=DOGOVOR_RDNS012_ot_29122014_g_za_priemane_na_obemi_i_ceni_na_medicinskata_pomos_za_2015_g_mejdu_Naci.pdf&groupId=10139. Accessed June 25, 2016
   Google Scholar
• Ordinance on the terms, rules and procedure for regulation and registration of prices for medicinal products. Effective as from April 30, 2013. www.ncpr.bg. Accessed July 4, 2016
   Google Scholar
• Real GDP per capita and growth rate. 2016. http://www.nsi.bg/bg. Accessed June 25, 2016
   Google Scholar
• Hoogendoorn M, Feenstra TL, Schermer TR, et al. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med 2006;100:83-6
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Lazic Z, Verhaeghe N, et al. Direct medical costs of COPD diagnosis and treatment, Eastern vs Western European country – examples of Serbia and Belgium. Health Econ Ther Pathw 2013;14:161-8
   Google Scholar
• Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res 2013;162:208-18
   PubMed Web of Science ®Google Scholar
• van Boven JFM, Román-Rodríguez M, Palmer JF, et al. Comorbidome, pattern and impact of asthma-COPD overlap syndrome (ACOS) in real life. Chest 2016;149:1011-20
   PubMed Web of Science ®Google Scholar
• Thomsen M, Nordestgaard, B, Vestbo J, et al. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med 2013;1:543-50
   PubMed Web of Science ®Google Scholar
• Mehta AJ, Miedinger D, Keidel D, et al. SAPALDIA Team. Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss cohort study on air pollution and lung and heart diseases in adults. Am J Respir Crit Care Med 2012;185:1292-300
   PubMed Web of Science ®Google Scholar
• van Gemert F, Kirenga B, Chavannes N, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health 2015;3:e44-51
   PubMed Web of Science ®Google Scholar
• Mazitova NN, Saveliev AA, Berheeva ZM, et al. COPD and occupation: a retrospective cohort study of industrial workers. Arh Hig Rada Toksikol 2012;63:345-56
   PubMed Web of Science ®Google Scholar
• Nagorni-Obradovic LM, Vukovic DS. The prevalence of COPD co-morbidities in Serbia: results of a national survey. NPJ Prim Care Respir Med 2014;24:14008
   PubMed Web of Science ®Google Scholar
• Battaglia S, Basile M, Scichilone N, et al. Prevalence of Cco-morbidities and severity of COPD. COPD 2015;12:390-4
   PubMedGoogle Scholar
• Lazic Z, Gajovıc O, Tanaskovic I, et al. GOLD stage impact on COPD direct medical costs in elderly. J Health Behav Public Health 2012;2:1-7
   Google Scholar
• Fletcher M, Upton J, Taylor-Fishwick J, et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health 2011;11:612
   PubMed Web of Science ®Google Scholar
• Magnussen H, Disse B, Rodriguez-Roisin R, et al. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med 2014;371:1285-94
   PubMed Web of Science ®Google Scholar
• The economic burden of lung disease. European Lung White Book. 2015. http://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/. Accessed June 25, 2016
   Google Scholar
• Zbozinkova Z, Barczyk A, Tkacova R, et al. POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe. Int J Chron Obstruct Pulmon Dis 2016;11:611-22
   PubMed Web of Science ®Google Scholar